pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-497 |
Genomic Coordinates | chr17: 7017911 - 7018022 |
Synonyms | MIRN497, hsa-mir-497, MIR497 |
Description | Homo sapiens miR-497 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-497-3p | ||||||||||||||||||||||||||||
Sequence | 64| CAAACCACACUGUGGUGUUAGA |85 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRIOBP | ||||||||||||||||||||
Synonyms | DFNB28, HRIHFB2122, TAP68, TARA, dJ37E16.4 | ||||||||||||||||||||
Description | TRIO and F-actin binding protein | ||||||||||||||||||||
Transcript | NM_001039141 | ||||||||||||||||||||
Other Transcripts | NM_007032 , NM_138632 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRIOBP | |||||||||||||||||||||
3'UTR of TRIOBP (miRNA target sites are highlighted) |
>TRIOBP|NM_001039141|3'UTR 1 AGGTCCCGCCCAGCTGCAGACCCTCCAGGCTGGAGGACCAGCCGCCCTCCTTCCCTCCTGGATGGAAGTAAAAAGCCAAG 81 CTTTCTCCCCACCCTCTGTGGGCCACACGTGCACTTGCACCCACCACACACACACACACACACACACACACACACACAGA 161 CACACAGACACATACGCACACACGTGCACACATGTACACACGGATACACACACACACACACACACTGCATATCTGAGCGC 241 GCCCCTCGCACTGGGTCTCACCTTGCACCTTCTTCAGGATTTTATATGTGAAGAGATTTTTATATAGATTTTTTTCCTTT 321 TTTTCCAAAACACTTTATACTTTAAAAAAAAAAAAAAAAAGCAATTCCTGGTGGCTGTGTGCCTCCAACCCTGGTCCCCC 401 TCTGTCTCCAGCCACCCTCTGCTTGGGCTTCTGAGCTGGTGGCCCTGGCCCAGAGGTCTGGCGGAGGCCCAGGCAGCAGC 481 CATGGCGGGGTGTCTCTACAGGGGAGAGGCGGGAGCCTGCCACCCTCTTCCTGCCCTACCTCCTACTAACACTTCCTGCC 561 CCATTTGGACCCGTACCATGGGGCTCAGGACAGAGGGAGCTAGCAGCTGGCCTCCATGGCCCCACAGCCTCCTTCGAGGC 641 TGTGCTGGGTGCAGAACCGCCAGAGCCACCCAAAAGGTGTTTCTCTTCTGCTCCCTGAACCTCTTAACTTAATAAAACGT 721 TCCAGCAGCTCTGGTGTCCTAGATGGCTGGCAGAACAGGAATGGAGATTGGGGTTTCTTGAAGTGGCTTCCCCACTCACA 801 CCCTACCCACACCCCACCCTTCCTAAAGCAGCGGCCTCTAGGCTTCTGAGGGTGGGGCTGAAAATCCAAGGTCTCCCTTA 881 GTACAGACTGTGACGCCCCCAGTGTGGCTTGCAGGCTAGTGGCAGCGGAAGCATGTGGGAAATAGCAAGTCCAGTCCCAC 961 CCCAACCTACTGAACCAGCGTCTGCATTTTAACAGGGTGCCCCAGTGATTCACGTGACCTTCAAAGTCTGAGGAGCCCTG 1041 GAGTAGGGCCCAGGGCCCAGGCCTGAGAGAGAGGCCTGGGGCTAAGACTAGCCCTGACCATGACCTTGGGCAAGTCACAC 1121 CCCTCACTGAGCCTCAGTTTGCTTCTCCATCAAATGGGTGTTTTTCTTTCAGTCCCAGTCCTCTCCTGAGGCTTTTCCCA 1201 GAGGTCATGCCCAGCCCTGGGCAGGGGTGAGGGCAGGGTTGTGGCTGCCAGGCACAGGTCCAGCGGGCTGGGAGTCCTCA 1281 CCATGGCTGGCTGTGCTGATTATGGTTGCATGGGGCTGGGAAGAGGTCCCATTTCTGAGCCACAGAAACAGGCCACATCC 1361 AGTAGGGGTCCTGGAAGGCTGTGAGAACCCAGAGGAGACCCTGACCCAGCCTGCAGGTAGAAGACTGCCTTTGGAGGCAG 1441 CTTTGAAAGATGACTCTTCCAGATGGAAGAATCAGGAAGGGCCTTCCCACGTGGAGGCACCAGCAGGAGCAAACGTCCCT 1521 GGTGTGTTCAGGCAAAGAGCCACAGGAGAGTGACCTCGTGGAGTGGGAAGAGATTGTTTCCCATTCCCTTGCCAGGGATT 1601 GGTTGAGGAATGGACAAGGCTTGCAGTTCACGCAAGCCAGTGAAATGCGAGGGGAAGTCTTGGGAGTGGGGTGGAGGAGG 1681 TCATCTGGGAAGGGTGTCCTTGGTCTTAAAAAGAGGCACAAGAGGCCGGGCGCGGTGGCTCTTGCCTATTATCCTAGCAC 1761 TTTGGGAGGCCAAGGCAGGGGGATCACTTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCT 1841 ACTAAAAATACAAAAAATTAGCCAGACGTGGTGCCAAGCACCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAAT 1921 CACTTGAACCCAGGAGGCAGAAGTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGCCTGTGTGACAAGGGCGAAACT 2001 CCATCTCAAAAAAAAAGGGGGAGGGTGGCGCAAGGAGAGGACACCTCTCTCCTGGCCCTGTCGCCATCTTCCCTCATCAA 2081 TAGCTAAAAATGGCAAAGAAGAAAGAGCCAGGACCCCGTGCCATCAAATCCTCCGGCCTTGTGCTGCCCTGTCTCGGCAC 2161 TGCTTGCCTTAGGAGATCAGGAGTGTTCCTAGCCACTGGGAGATGGGATGCCTGCCACTGGCAGCTCTGCCGTCCATCCT 2241 CACCATCCCACCGTCCCCCCAAGACAGCTCTCCATCCCATCCTCTGCCTCCCTTCTAGCCTCAACCTAACTCAGGGCTCC 2321 CCCGTCTCACACCTGGGTTGCAGGAACATCCTCTTCACCAACCCCCCTCCCATCCCTCCTCAGGGCTGCCTAGGGCAGCT 2401 ACAAAAACCAGGCCAGCCTCTGAAAGGTGCTCCACATCTCATTAAAAACCGTGAAATCGCACTGCCCCACTATCAGAATA 2481 GCTCAGAGGAGAAGGTCTGCCAGTACCAAGTGCTGGTGGGGATACGGAGAAGAGCAGCTCCCAGGCGCTGCTGGTGCAAA 2561 TGTGCTTTGTTGCACCCACGGCAGGAAACTGACCAGCTTCTCATCAAGTTAAATACGCATCTACCCTATGGCCTAGCATT 2641 TCCACTCTTGCTTACACATCCAGGAGAAATGAGTCCTTACATGCACAAAAGGATGAGTACCGTAATACTCACATCAGCAA 2721 ATAAACAATACAGCTGTGTGTCAGTAGTAGAATGAATAAATTGTGGTCGATTCATAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-3 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000406386.3 | 3UTR | UUGGCUGCAAGUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
95 hsa-miR-497-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT092955 | CYP2U1 | cytochrome P450 family 2 subfamily U member 1 | 2 | 4 | ||||||||
MIRT124568 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT125196 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 4 | ||||||||
MIRT147296 | KPNA2 | karyopherin subunit alpha 2 | 2 | 8 | ||||||||
MIRT163999 | KIAA1109 | KIAA1109 | 2 | 4 | ||||||||
MIRT252495 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT357969 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT443007 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT443524 | NETO1 | neuropilin and tolloid like 1 | 2 | 2 | ||||||||
MIRT443573 | EVX2 | even-skipped homeobox 2 | 2 | 2 | ||||||||
MIRT443656 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT460670 | KRT10 | keratin 10 | 2 | 8 | ||||||||
MIRT464761 | UBE2N | ubiquitin conjugating enzyme E2 N | 2 | 2 | ||||||||
MIRT465032 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT465040 | TTC39C | tetratricopeptide repeat domain 39C | 2 | 2 | ||||||||
MIRT468667 | SEC62 | SEC62 homolog, preprotein translocation factor | 2 | 2 | ||||||||
MIRT473694 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 4 | ||||||||
MIRT477618 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT480506 | C11orf57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT480592 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT486915 | ZNF398 | zinc finger protein 398 | 2 | 6 | ||||||||
MIRT487770 | ANKEF1 | ankyrin repeat and EF-hand domain containing 1 | 2 | 16 | ||||||||
MIRT493265 | MDFIC | MyoD family inhibitor domain containing | 2 | 2 | ||||||||
MIRT495271 | SLC1A2 | solute carrier family 1 member 2 | 2 | 4 | ||||||||
MIRT495309 | CHST12 | carbohydrate sulfotransferase 12 | 2 | 2 | ||||||||
MIRT496681 | DPP6 | dipeptidyl peptidase like 6 | 2 | 4 | ||||||||
MIRT496891 | FOXP1 | forkhead box P1 | 2 | 2 | ||||||||
MIRT497330 | IRF4 | interferon regulatory factor 4 | 2 | 2 | ||||||||
MIRT498272 | KIAA1644 | KIAA1644 | 2 | 2 | ||||||||
MIRT498634 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 10 | ||||||||
MIRT500581 | USP53 | ubiquitin specific peptidase 53 | 2 | 2 | ||||||||
MIRT500751 | TMPPE | transmembrane protein with metallophosphoesterase domain | 2 | 6 | ||||||||
MIRT509668 | ZNF354B | zinc finger protein 354B | 2 | 10 | ||||||||
MIRT510919 | PSMA2 | proteasome subunit alpha 2 | 2 | 4 | ||||||||
MIRT519118 | CEP76 | centrosomal protein 76 | 2 | 2 | ||||||||
MIRT526193 | ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | 2 | 2 | ||||||||
MIRT526746 | HLA-DOB | major histocompatibility complex, class II, DO beta | 2 | 2 | ||||||||
MIRT527270 | FBLN2 | fibulin 2 | 2 | 2 | ||||||||
MIRT528198 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | 2 | 2 | ||||||||
MIRT528330 | TBC1D22B | TBC1 domain family member 22B | 2 | 2 | ||||||||
MIRT530346 | GABRB3 | gamma-aminobutyric acid type A receptor beta3 subunit | 2 | 2 | ||||||||
MIRT533627 | TMX3 | thioredoxin related transmembrane protein 3 | 2 | 2 | ||||||||
MIRT533738 | TMEM200C | transmembrane protein 200C | 2 | 2 | ||||||||
MIRT533779 | TMEM133 | transmembrane protein 133 | 2 | 2 | ||||||||
MIRT534317 | SKIDA1 | SKI/DACH domain containing 1 | 2 | 2 | ||||||||
MIRT538438 | COG5 | component of oligomeric golgi complex 5 | 2 | 2 | ||||||||
MIRT539156 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT539474 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | 2 | 2 | ||||||||
MIRT539620 | SHISA9 | shisa family member 9 | 2 | 2 | ||||||||
MIRT539650 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 2 | 2 | ||||||||
MIRT540346 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT540412 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 2 | 2 | ||||||||
MIRT541200 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 2 | ||||||||
MIRT541395 | CDC27 | cell division cycle 27 | 2 | 2 | ||||||||
MIRT546443 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT547369 | MSI2 | musashi RNA binding protein 2 | 2 | 2 | ||||||||
MIRT553288 | TSPAN3 | tetraspanin 3 | 2 | 2 | ||||||||
MIRT554402 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT557822 | FOXN2 | forkhead box N2 | 2 | 2 | ||||||||
MIRT568530 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 2 | ||||||||
MIRT569508 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT570707 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT608376 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | 2 | 2 | ||||||||
MIRT608483 | NKTR | natural killer cell triggering receptor | 2 | 6 | ||||||||
MIRT613533 | TRA2B | transformer 2 beta homolog | 2 | 2 | ||||||||
MIRT616601 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT618166 | DUSP18 | dual specificity phosphatase 18 | 2 | 2 | ||||||||
MIRT632059 | CEP135 | centrosomal protein 135 | 2 | 2 | ||||||||
MIRT647379 | ZDHHC23 | zinc finger DHHC-type containing 23 | 2 | 2 | ||||||||
MIRT648366 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT651075 | ZNF518B | zinc finger protein 518B | 2 | 4 | ||||||||
MIRT653618 | SLC30A4 | solute carrier family 30 member 4 | 2 | 2 | ||||||||
MIRT653636 | SLC30A1 | solute carrier family 30 member 1 | 2 | 2 | ||||||||
MIRT654895 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT656232 | MFSD6 | major facilitator superfamily domain containing 6 | 2 | 2 | ||||||||
MIRT659880 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT660526 | ARL4C | ADP ribosylation factor like GTPase 4C | 2 | 2 | ||||||||
MIRT666286 | SLC30A3 | solute carrier family 30 member 3 | 2 | 2 | ||||||||
MIRT686808 | SNX2 | sorting nexin 2 | 2 | 4 | ||||||||
MIRT695302 | TK1 | thymidine kinase 1 | 2 | 2 | ||||||||
MIRT699737 | SERINC3 | serine incorporator 3 | 2 | 2 | ||||||||
MIRT700794 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT712270 | PPP1CB | protein phosphatase 1 catalytic subunit beta | 2 | 2 | ||||||||
MIRT712617 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | 2 | 2 | ||||||||
MIRT714264 | RPL10A | ribosomal protein L10a | 2 | 2 | ||||||||
MIRT715072 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT715386 | TADA3 | transcriptional adaptor 3 | 2 | 2 | ||||||||
MIRT716397 | NPAS1 | neuronal PAS domain protein 1 | 2 | 2 | ||||||||
MIRT725328 | NFASC | neurofascin | 2 | 2 | ||||||||
MIRT725503 | GANAB | glucosidase II alpha subunit | 2 | 2 | ||||||||
MIRT732913 | IRAK2 | interleukin 1 receptor associated kinase 2 | 3 | 0 | ||||||||
MIRT734890 | SMAD3 | SMAD family member 3 | 3 | 0 | ||||||||
MIRT737328 | LINC02476 | long intergenic non-protein coding RNA 2476 | 3 | 0 | ||||||||
MIRT737544 | MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | 4 | 0 | ||||||||
MIRT755545 | PAK1 | p21 (RAC1) activated kinase 1 | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|